In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials (PDQ®)

Page Options

  • Print This Page
  • Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Basic Trial Information
Trial Description
     Summary
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentActive1 to 17Pharmaceutical / IndustryCA180-372
2011-001123-20, AALL1122, NCT01460160

Trial Description

Summary

The purpose of this study is to determine whether Dasatinib when added to standard chemotherapy is effective and safe in the treatment of pediatric philadelphia chromosome positive acute lymphoblastic leukemia

Eligibility Criteria

Inclusion Criteria:

  • Newly diagnosed Philadelphia chromosome positive Acute Lymphoblastic Leukemia (ALL)
  • Age >1 year and < less than 18 years old
  • Induction chemotherapy ≤ 14 days according to institutional standard of care
  • Adequate liver, renal and cardiac function

Exclusion Criteria:

  • Prior treatment with a Oncogene fusion protein (BCR-ABL) inhibitor
  • Extramedullary involvement of the testicles
  • Active systemic bacterial, fungal or viral infection
  • Down syndrome

Trial Contact Information

Trial Lead Organizations/Sponsors

Bristol-Myers Squibb Company - New York

Children's Oncology Group

EsPhALL - European Intergroup Study on Post Induction Treatment of Philadelphia Positive Acute Lymphoblastic Leukaemia with Imatinib

Bristol-Myers SquibbStudy Director

For participation information at a USA site use a phone number below. For site information outside the USA please email:
  Email: Clinical.Trials@bms.com

Trial Sites

U.S.A.
Alabama
  Birmingham
 UAB Comprehensive Cancer Center
 Alyssa T Reddy, Site 077 Ph: 205-939-9285
Arkansas
  Little Rock
 Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
 David L Becton, Site 098 Ph: 501-364-5650
California
  Loma Linda
 Antranik Agop Bedros
 Antranik Agop Bedros, Site 099 Ph: 909-558-4050
  Long Beach
 Jonathan Jaques Children's Cancer Center at Miller Children's Hospital
 Amanda Termuhlen, Site 046 Ph: 562-933-8600
  Los Angeles
 Childrens Hospital Los Angeles
 Weili Sun, Site 014 Ph: 323-361-8186
  Orange
 Children's Hospital of Orange County
 Violet Shen, Site 019 Ph: 714-516-4348
  Palo Alto
 Lpch & Sumc
 Neyssa Marina, Site 036 Ph: 650-723-5535
  Roseville
 Kaiser Medical Center
 Steven Bergstrom, Site 101 Ph: 916-474-2170
Colorado
  Aurora
 Children's Hospital Colorado Center for Cancer and Blood Disorders
 Kelly Maloney, Site 072 Ph: 720-777-6673
Connecticut
  Hartford
 Connecticut Children's Medical Center
 Michael Isakoff, Site 025 Ph: 860-545-9630
Delaware
  Wilmington
 Alfred I. duPont Hospital for Children
 Christopher N Frantz, Site 008 Ph: 302-651-5500
District of Columbia
  Washington
 Children's National Medical Center
 Jeffrey Dome, Site 018 Ph: 202-476-2800
Florida
  Fort Myers
 Lee Cancer Care of Lee Memorial Health System
 Emad Salman, Site 034 Ph: 239-343-5333
  Jacksonville
 Nemours Children's Clinic
 Eric Sandler, Site 049 Ph: 904-697-3793
  Orlando
 M.D. Anderson Cancer Center at Orlando
 Vincent Giusti, Site 037 Ph: 321-841-1859
 Nemours Children'S Clinic - Orlando
 Ramamoorthy Nagasubramanian, Site 050 Ph: 407-650-7230
  St. Petersburg
 All Children's Hospital
 Gregory Alan Hale, Site 009 Ph: 727-747-2423
Illinois
  Chicago
 Ann and Robert H. Lurie Children's Hospital of Chicago
 Nobuko Hijiya, Site 022 Ph: 773-880-4562
  Springfield
 Simmons Cooper Cancer Institute
 Gregory Brandt, Site 067 Ph: 217-545-7377
Indiana
  Indianapolis
 Children'S Center For Cancer And Blood Diseases
 Bassem Razzouk, Site 062 Ph: 317-338-4673
 James Whitcomb Riley Hospital For Children
 Robert J Fallon, Site 030 Ph: 317-944-8784
Massachusetts
  Boston
 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
 Lewis Silverman, Site 104 Ph: 617-632-6191
Michigan
  Detroit
 Children's Hospital of Michigan
 Meret Henry, Site 105 Ph: 313-745-5649
Mississippi
  Jackson
 Univ Of Mississippi Med Ctr
 Gail Megason, Site 085 Ph: 601-984-5220
Missouri
  Kansas City
 Children's Mercy Hospital
 Maxine Hetherington, Site 073 Ph: 816-234-3265
  St. Louis
 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
 Robert Hayashi, Site 092 Ph: 314-454-6018
Nevada
  Las Vegas
 Children's Specialty Center of Nevada
 Jonathan Bernstein, Site 051 Ph: 702-384-0013
New Jersey
  Hackensack
 Hackensack University Medical Center Cancer Center
 Burton Elliot Appel, Site 029 Ph: 201-996-5437
  Morristown
 Goryeb Children'S Hospital
 Steven Halpern, Site 097 Ph: 973-971-6720
  Paterson
 St. Joseph's Hospital and Medical Center
 Mary Ann Bonilla, Site 060 Ph: 973-754-3349
New York
  Syracuse
 SUNY Upstate Medical University Hospital
 Karol H. Kerr, Site 070 Ph: 315-464-5294
  Valhalla
 New York Medical College
 Mehmet Ozkaynak, Site 109 Ph: 914-594-3062
North Carolina
  Charlotte
 Levine Children's Hospital
 Joel Kaplan, Site 011 Ph: 704-381-9900
Ohio
  Cincinnati
 Cincinnati Children's Hospital Medical Center
 Maureen O'Brien, Site 023 Ph: 513-803-1678
  Columbus
 Nationwide Children's Hospital
 Laura T. Martin, Site 048 Ph: 614-722-3552
  Dayton
 The Children'S Medical Center Of Dayton
 Emmett Broxson, Site 017 Ph: 937-641-3111
  Toledo
 Mercy Children's Hospital
 Rama Jasty, Site 115 Ph: 419-251-8223
Oklahoma
  Oklahoma City
 Oklahoma University Cancer Institute
 Rene Y Mcnall-Knapp, Site 089 Ph: 405-271-5311
Oregon
  Portland
 Legacy Emanuel Hospital and Health Center and Children's Hospital
 Janice F Olson, Site 035 Ph: 503-276-9300
Pennsylvania
  Danville
 Geisinger Cancer Institute at Geisinger Health
 Jeffrey Taylor, Site 007 Ph: 570-271-6848
  Hershey
 Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
 John Kuttesch, Site 053 Ph: 717-531-6012
  Philadelphia
 Children's Hospital of Philadelphia
 Richard D Aplenc, Site 015 Ph: 267-426-7252
  Pittsburgh
 Children's Hospital of Pittsburgh of UPMC
 A. Kim Ritchey, Site 016 Ph: 412-692-5949
Tennessee
  Knoxville
 East Tennessee Children's Hospital
 Ray Pais, Site 028 Ph: 865-541-8266
Texas
  Austin
 Dell Children's Medical Center of Central Texas
 Sharon K Lockhart, Site 112 Ph: 512-628-1900
  Corpus Christi
 Driscoll Children's Hospital
 Cris Johnson, Site 027 Ph: 361-694-5311
  Dallas
 Ut Southwestern
 Naomi Winick, Site 091 Ph: 214-648-2912
  Fort Worth
 Cook Children's Medical Center - Fort Worth
 Kelly Vallance, Site 026 Ph: 682-885-1904
  Houston
 Baylor College Of Med/Tx Chldrns Cancer & Hem Ctrs.
 Maria Gramatges, Site 010 Ph: 832-824-4678
  Temple
 Scott and White Cancer Institute
 Guy Grayson, Site 063 Ph: 254-724-5382
Virginia
  Norfolk
 Children'S Hosp-Kings Daughter
 Eric Lowe, Site 020 Ph: 757-668-7243
Wisconsin
  Green Bay
 St Vincent Hospital
 John R Hill, Site 061 Ph: 920-433-8670
  Milwaukee
 Medical College of Wisconsin Cancer Center
 Richard Tower, Site 045 Ph: 414-456-4170
Australia
  Perth
 Local Institution
 Site 132
Queensland
  Herston
 Local Institution
 Site 130
Canada
Ontario
  London
 Local Institution
 Site 120
Quebec
  Montreal
 Local Institution
 Site 125
 Site 119
Italy
  Bologna
 Local Institution
 Site 146
  Cagliari
 Local Institution
 Site 141
  Catania
 Local Institution
 Site 133
  Firenze
 Local Institution
 Site 137
  Monza (Mb)
 Local Institution
 Site 134
  Napoli
 Local Institution
 Site 142
  Palermo
 Local Institution
 Site 139
  Roma
 Local Institution
 Site 145
  Torino
 Local Institution
 Site 143
  Trieste
 Local Institution
 Site 135
Puerto Rico
  San Juan
 Local Institution
 Site 096
United Kingdom
  Birmingham
 Local Institution
 Site 148
  Manchester
 Local Institution
 Site 152
  Newcastle
 Local Institution
 Site 153
  Nottingham
 Local Institution
 Site 163
  Sheffield
 Local Institution
 Site 166

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01460160
Information obtained from ClinicalTrials.gov on December 19, 2012

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.

Back to TopBack to Top